NCT00552032View on ClinicalTrials.gov

Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155)

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

August 1, 2007

Primary Completion Date

January 1, 2010

Study Completion Date

January 1, 2010

Conditions
Adenoids Hypertrophy
Interventions
DRUG

Mometasone Furoate nasal spray

Mometasone Furoate nasal spray 1 puff (50 mcg) per nostril twice daily x 8 weeks. There was a blinded follow-up period of 16 weeks, resulting in study duration of 24 weeks (6 months).

DRUG

Placebo

Placebo nasal spray 1 puff per nostril twice daily x 8 weeks. There was a blinded follow-up period of 16 weeks, resulting in study duration of 24 weeks (6 months).

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00552032 - Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155) | Biotech Hunter | Biotech Hunter